-
全球的RNAi药物输送市场报告(2014-2018年)
The increase in the understanding of genomics and drug delivery systems facilitated the development of RNA therapeutics as a mode of drug delivery. RNAi drug delivery systems offer better bioavailability and mode of action for effective therapeutic benefits. Three types of RNAi drug delivery technologies include the nanoparticle-based RNAi delivery system, the nucleicacid-based drug delivery method, and the aptamer-based RNAi drug delivery system. The nanoparticle-based RNAi drug delivery systems represent the most popular system; while the nucleic-acid-based drug delivery method and the aptamer-based RNAi drug delivery system represent the niche upcoming technologies.
-
全球中心静脉通路装置市场报告(2014-2018年)
Central venous access devices are devices inserted into the central venous system to administer medication or fluids, draw blood, and measure central venous pressure. These devices are made up of a non-irritant material such as silicone so that they can be left in place for several weeks or months. Central venous access devices are recommended when there is difficultly to obtain peripheral venous access or in case of certain intravenous therapies such as chemotherapy, total parenteral nutrition, prolonged medication, repeated transfusions of blood or blood products, and frequent blood sampling. These devices are inserted either by surgeons or interventional radiologists with or without the use of general anesthesia. CVCs, PICCS, and implantable ports are the most common types of central venous access device. The catheter has one end positioned outside the body and the ports are surgically placed under the skin and require a special needle for access. Occlusions are a common complication associated with these devices, which can be thrombotic, mechanical, and precipitate occlusions.
-
全球性肌萎缩侧索硬化症市场报告(2014-2018年)
ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects neurons in the brain and spinal cord. In ALS, degeneration of the motor neurons leads to their death. As a result the brain loses its ability to initiate and control muscle movement. Patients in the later stages of the disease may turn out to be totally paralyzed. Muscle twitches, cramps, tight and stiff muscles, slurred and nasal speech, and difficulties in chewing or swallowing are some of the common symptoms observed in ALS patients.